Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (1): 27-31.doi: 10.6040/j.issn.1673-3770.0.2022.440

• Original Article • Previous Articles     Next Articles

To analyze the mortality trend of nasopharyngeal carcinoma based on Joinpoint regression and an age-period-cohort model

DAI Honglei1, WANG Qiuyang2, MA Wenxue1, GUAN Bin1, QI Jingjing1   

  1. 1. Department of Otolaryngology, Jingmen People's Hospital, Jingchu Institute of Technology Affiliated Central Hospital, Jingmen 448000, Hubei, China2. Department of Otolaryngology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China
  • Published:2024-01-12

PDF (PC)

513

Abstract: Objective To explore the long-term development trend of nasopharyngeal carcinoma mortality in China from 1990 to 2019. Methods Data obtained from the GHDx database established by the Global Burden of Disease Project was analyzed in this study. The Joinpoint regression model was used to analyze the trend of NPC mortality in China, and the age-period-cohort model was used to estimate the age effect, period effect, and cohort effect on nasopharyngeal carcinoma mortality risk in China. Results Overall, from 1990 to 2019, the nasopharyngeal carcinoma mortality rate in China showed a downward trend year by year. The Joinpoint regression model showed that the overall trend was divided into five segments, and the AAPC value was -2.454%. The trend of nasopharyngeal carcinoma mortality in males could be divided into five segments, with an AAPC value of -1.958%. The change trend of female nasopharyngeal carcinoma mortality can be divided into six segments, and the AAPC value was -3.498%. Additionally, increasing age significantly increases nasopharyngeal carcinoma mortality, and the cycle effect of mortality generally shows an upward trend. Conclusion The cohort reduction effect may lead to a decrease in nasopharyngeal carcinoma mortality, while an increase in age and the cycle effect may lead to an increase in cancer mortality.

Key words: Nasopharyngeal carcinoma, Mortality, Joinpoint regression model, Age-period-ohort model

CLC Number: 

  • R739.6
[1] 陈万青, 郑荣寿, 张思维, 等. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8. doi:10.11735/j.issn.1004-0242.2016.01.A001 CHEN Wanqing, ZHENG Rongshou, ZHANG Siwei, et al. Report of cancer incidence and mortality in China, 2012[J]. China Cancer, 2016, 25(1): 1-8. doi:10.11735/j.issn.1004-0242.2016.01.A001
[2] Chen WQ, Zheng RS, Zhang SW, et al. Report of incidence and mortality in China Cancer Registries, 2008[J]. Chinese Journal of Cancer Research, 2012, 24(3): 171-180. doi:10.1007/s11670-012-0171-2
[3] 孙盼盼, 刘莉, 平智广, 等. 不同地区癌症发病分布特征及聚类分析[J]. 中国癌症杂志, 2016, 26(6): 499-507. doi:10.19401/j.cnki.1007-3639.2016.06.004 SUN Panpan, LIU Li, PING Zhiguang, et al. The exploration of characteristics of cancer incidence in cancer surveillance areas by correspondence analysis and cluster analysis[J]. China Oncology, 2016, 26(6): 499-507. doi:10.19401/j.cnki.1007-3639.2016.06.004
[4] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3): 209-249. doi:10.3322/caac.21660
[5] 陆海军, 刘霁, 丁晓. 鼻咽癌的综合治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 26-30. doi:10.6040/j.issn.1673-3770.1.2019.010 LU Haijun, LIU Ji, DING Xiao. Progress in the comprehensive treatment for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 26-30. doi:10.6040/j.issn.1673-3770.1.2019.010
[6] 周宇翔, 苗北平,卢永田.首诊鼻咽癌内镜手术的治疗进展[J].山东大学耳鼻喉眼学报, 2021. 35(6): 108-112. doi: 10.6040 / j.issn.1673-3770.0.2020.49 ZHOU Yuxiang, MIAO Beiping, LU Yongtian. Treatment progress of endoscopic surgery for first diagnosed nasopharyngeal carci-noma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 108-112. doi: 10.6040 / j.issn.1673-3770.0.2020.49
[7] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi:10.1016/s0140-6736(19)30956-0
[8] Hongmei, Zeng, PhD, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. The Lancet Global Health, 2018, 6(5): e555-e567. doi:10.1016/S2214-109X(18)30127-X
[9] Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA: A Cancer Journal for Clinicians, 2017, 67(2): 93-99. doi:10.3322/caac.21388
[10] 刘晓雪, 张志将, 宇传华. 中国居民1987~2015年鼻咽癌死亡趋势[J]. 中南大学学报(医学版), 2018, 43(7): 760-766. doi:10.11817/j.issn.1672-7347.2018.07.010 LIU Xiaoxue, ZHANG Zhijiang, YU Chuanhua. Mortality trend in nasopharynx cancer in Chinese resident from 1987 to 2015[J]. Journal of Central South University(Medical Science), 2018, 43(7): 760-766. doi:10.11817/j.issn.1672-7347.2018.07.010
[11] 项鑫, 王乙. 中国人口老龄化现状、特点、原因及对策[J]. 中国老年学杂志, 2021, 41(18): 4149-4152. doi:10.3969/j.issn.1005-9202.2021.18.072 XIANG Xin, WANG Yi. The present situation, characteristics, causes and countermeasures of population aging in China[J]. Chinese Journal of Gerontology, 2021, 41(18): 4149-4152. doi:10.3969/j.issn.1005-9202.2021.18.072
[12] Aussem A, Morais SR, Corbex M. Analysis of nasopharyngeal carcinoma risk factors with Bayesian networks[J]. Artificial Intelligence in Medicine, 2012, 54(1): 53-62. doi:10.1016/j.artmed.2011.09.002
[13] Lourembam DS, Singh AR, Sharma TD, et al. Evaluation of risk factors for nasopharyngeal carcinoma in a high-risk area of India, the northeastern region[J]. Asian Pacific Journal of Cancer Prevention, 2015, 16(12): 4927-4935. doi:10.7314/apjcp.2015.16.12.4927
[14] Jia WH, Qin HD. Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review[J]. Seminars in Cancer Biology, 2012, 22(2): 117-126. doi:10.1016/j.semcancer.2012.01.009
[15] 何朝光, 傅万凯, 陈彩霞, 等. 1990和2017年中国鼻咽癌疾病负担及其趋势[J]. 海峡预防医学杂志, 2020, 26(4): 108-110 HE Chaoguang, FU Wankai, CHEN Caixia, et al. The disease burden and trend of nasopharyngeal carcinoma in China in 1990 and 2017[J]. Strait Journal of Preventive Medicine, 2020, 26(4): 108-110
[16] 魏矿荣, 梁智恒, 欧志雄. 广东省中山市1970~2010年鼻咽癌死亡概况[J]. 中国癌症杂志, 2014, 24(4): 241-245. doi:10.3969/j.issn.1007-3969.2014.04.001 WEI Kuangrong, LIANG Zhiheng, OU Zhixiong. Zhongshan nasopharyngeal carcinoma(NPC)mortality in 1970-2010[J]. China Oncology, 2014, 24(4): 241-245. doi:10.3969/j.issn.1007-3969.2014.04.001
[17] 邹艳花, 廖先珍, 许可葵, 等. 2009~2012年湖南省肿瘤登记地区鼻咽癌的发病与死亡分析[J]. 实用预防医学, 2016, 23(12): 1415-1418. doi:10.3969/j.issn.1006-3110.2016.12.003 ZOU Yanhua, LIAO Xianzhen, XU Kekui, et al. Analysis of incidence and death of nasopharyngeal carcinoma in tumor registration areas of Hunan Province from 2009 to 2012[J]. Practical Preventive Medicine, 2016, 23(12): 1415-1418. doi:10.3969/j.issn.1006-3110.2016.12.003
[18] 容敏华, 李秋林, 曹骥, 等. 2013年广西肿瘤登记地区鼻咽癌发病和死亡分析[J]. 中国癌症防治杂志, 2017, 9(2): 104-110. doi:10.3969/j.issn.1674-5671.2017.02.05 RONG Minhua, LI Qiulin, CAO Ji, et al. Nasopharyngeal cancer incidence and mortality in Guangxi in 2013[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 104-110. doi:10.3969/j.issn.1674-5671.2017.02.05
[19] 赵平,孔灵芝. 中国肿瘤死亡报告: 全国第三次死因回顾抽样调查[M]. 北京: 人民卫生出版社, 2010: 170-187
[1] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[2] XIAO Junhua, PAN Qingchun, JIN Shu. Trend and projection of larynx cancer mortality caused by occupational exposure to sulfuric acid [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 55-61.
[3] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[4] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[5] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[6] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[7] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[8] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[9] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[10] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[11] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[12] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
[13] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[14] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[15] ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd